Knight Therapeutics | GUD - Capitale Sociale E Riserve

Prezzo Delle Azioni
7.50
Cambio Giornaliero
0.05 0.67%
Mensile
1.21%
Annuale
22.35%
Q2 Previsione
7.39




Capitale Sociale E Riserve Cambiamento Data
Acasti Pharma USD 62.82M 732K 2025-09
Akebia Therapeutics USD 32.61M 8.98M 2025-12
Alaunos Therapeutics USD 2.15M 650K 2025-12
Aurora Cannabis CAD 536.36M 30.74M 2025-12
Avita Medical AUD -16.65M 3.76M 2025-12
Canopy Growth CAD 758.17M 22.16M 2025-12
Cronos Group USD 1.09B 11.39M 2025-12
Dianthus Therapeutics USD 493.4M 53.05M 2025-12
Ionis Pharmaceuticals USD 491.41M 2.32M 2026-03
IQVIA Holdings USD 6.5B 343M 2025-12
Knight Therapeutics CAD 767.27M 480K 2025-12
Moderna USD 8.65B 680M 2025-12
Omeros USD -228.68M 15.13M 2025-06
Organigram Holdings CAD 369.46M 20.33M 2025-12
Organon & Co USD 752M 154M 2025-12
Revvity USD 7.38B 180.27M 2025-09
Tectonic Therapeutic USD 251.33M 16.2M 2025-12
Tilray USD 1.58B 39.08M 2025-09
Viatris USD 15.22B 352.9M 2025-09
Xeris Pharmaceuticals USD 13.69M 14.55M 2025-12